| Literature DB >> 31193855 |
Kimberly Tay1, Anojan Navaratnam1, Sean McAdams1, Mira Keddis1, Matthew Neville2, Mitchell R Humphreys1.
Abstract
OBJECTIVE: To identify factors that predict kidney stone patient's ability to produce 2.5 L urine volume per day on metabolic evaluation. PATIENTS AND METHODS: In a retrospective chart review, the first analysis evaluated initial 24-hour urine collections with respect to those who achieved or did not achieve a urine volume of 2.5 L/day. The second analysis evaluated those who achieved or did not achieve a daily urine volume of 2.5 L on their subsequent collection. Several variables were assessed.Entities:
Keywords: AUA, American Urological Association; BMI, body mass index; Cr24/Kg, creatinine per kilogram; SSCaOx, supersaturation of calcium oxalate
Year: 2019 PMID: 31193855 PMCID: PMC6543444 DOI: 10.1016/j.mayocpiqo.2019.02.006
Source DB: PubMed Journal: Mayo Clin Proc Innov Qual Outcomes ISSN: 2542-4548
Variables Associated With Achieving 2.5 L/day Urine Volume on the Initial Collectionab
| Variable | Urine volume | ||
|---|---|---|---|
| <2.5 L on the initial collection (n=826) | ≥2.5 L on the initial collection (n=274) | ||
| Sex (n=1100) | .013 | ||
| Female (n=448) | 354/826 (42.9) | 94/274 (34.3) | |
| Male (n=652) | 472/826 (57.1) | 180/274 (65.7) | |
| Age (y) | 58.2±15.1 | 56.7±13.3 | .016 |
| BMI (kg/m2) | 27.7±6.3 | 28.7±6.8 | .025 |
| Urine dietary factors (n=1100) | |||
| Urine sodium level (mmol/dL) | 151±68.5 | 203.7±90.3 | <.0001 |
| Urine phosphorus level (g/d) | 0.9±0.3 | 1.0±0.3 | <.0001 |
| Urine calcium level (mg/d) | 196.0±110.4 | 256.0±135.5 | <.0001 |
| SSCaOx | 7.6±3.5 | 4.6±2.4 | <.0001 |
| UUN level (g/d) | 10.0±4.0 | 12.7±4.2 | <.0001 |
| PCR (g/kg per day) | 1.0±0.3 | 1.1±0.3 | <.0001 |
| Comorbidities requiring fluid restriction (n=1046) | |||
| Heart failure | 26/782 (3.3) | 7/264 (2.7) | .59 |
| Hyponatremia | 32/782 (4.1) | 17/264 (6.4) | .12 |
| Cirrhosis | 13/782 (1.7) | 3/264 (1.1) | .55 |
| Medications at presentation (n=1043) | |||
| Hydrochlorothiazide | 28/781 (3.6) | 7/262 (2.7) | .48 |
| Chlorthalidone | 235/781 (30.1) | 85/262 (32.5) | .47 |
| Indapamide | 8/781 (1.0) | 3/262 (1.1) | .87 |
| Amiloride | 9/781 (1.2) | 4/262 (1.5) | .64 |
| Furosemide | 26/781 (3.3) | 4/262 (1.5) | .13 |
| Bumetanide | 0/781 (0) | 1/262 (0.4) | .084 |
| Torsemide | 1/781 (0.1) | 2/262 (0.8) | .097 |
| Potassium citrate | 113/781 (14.5) | 33/262 (12.6) | .45 |
| Sodium bicarbonate | 3/781 (0.4) | 1/262 (0.4) | >.99 |
| Collection day | .36 | ||
| Sunday | 227/826 (27.5) | 77/274 (28.1) | |
| Monday | 165/826 (20.0) | 60/274 (21.9) | |
| Tuesday | 141/826 (17.1) | 38/274 (13.9) | |
| Wednesday | 112/826 (13.6) | 48/274 (17.5) | |
| Thursday | 103/826 (12.5) | 34/274 (12.4) | |
| Friday | 50/826 (6.1) | 12/274 (4.4) | |
| Saturday | 28/826 (3.4) | 5/274 (1.8) | |
| Weekday vs weekend | .77 | ||
| Weekday | 571/826 (69.1) | 192/274 (70.1) | |
| Weekend | 255/826 (30.9) | 82/274 (29.9) | |
BMI = body mass index; PCR = protein catabolic rate; SSCaOx = supersaturation of calcium oxalate; UUN = urine urea nitrogen.
Data are presented as mean ± SD or as number/total number (percentage).
Any P value less than .05.
Creatinine per Kilogram (Cr24/Kg) on the Initial Collectiona
| Variable | Urine volume | ||
|---|---|---|---|
| <2.5 L on the initial collection | ≥2.5 L on the initial collection | ||
| Men | 20.0±4.7 | 22.1±4.6 | <.0001 |
| Women | 16.8±4.6 | 18.4±4.5 | .0020 |
Data are presented as mean ± SD.
Any P value less than .05.
Variables Associated With Achieving 2.5 L/d Urine Volume on the Subsequent Collectionab
| Variable | Urine volume | ||
|---|---|---|---|
| <2.5 L on the subsequent collection (n=165) | ≥2.5 L on the subsequent collection (n=108) | ||
| Sex (n=273) | .67 | ||
| Female (n=118) | 73/165 (44.2) | 45/108 (41.7) | |
| Male (n=155) | 92/165 (55.8) | 63/108 (58.3) | |
| Age (y) | 60.8±14.4 | 59.4±14.4 | .40 |
| BMI (kg/m2) | |||
| Initial collections | 27.5±6.2 | 28.0±6.1 | .45 |
| Subsequent collection | 27.2±6.3 | 28.4±6.1 | .12 |
| Change | −0.2±2.3 | 0.0±1.5 | .93 |
| Insurance | .69 | ||
| Medicare | 79/156 (50.6) | 51/106 (48.1) | |
| Not Medicare | 77/156 (49.4) | 55/106 (51.9) | |
| Urine volume | |||
| Initial collections | 1.5±0.5 | 1.9±0.4 | <.0001 |
| Subsequent collection | 1.7±0.5 | 3.3±0.5 | <.0001 |
| Change | 0.3±0.5 | 1.4±0.6 | <.0001 |
| Urine dietary factors | |||
| Urine sodium level (mmol/dL) | |||
| Initial collections | 147.2±54.4 | 168.0±66.3 | .025 |
| Subsequent collection | 159.5±67.7 | 191.2±80.1 | .0026 |
| Change | 12.3±58.2 | 23.2±67.2 | .16 |
| Urine phosphorus level (g/d) | |||
| Initial collections | 0.8±0.3 | 0.9±0.3 | .052 |
| Subsequent collection | 0.8±0.3 | 0.9±0.3 | .22 |
| Change | 0.0±0.3 | 0.0±0.3 | .28 |
| Urine calcium level (mg/d) | |||
| Initial collections | 185.9±99.1 | 223.3±102.3 | .0016 |
| Subsequent collection | 173.0±96.8 | 197.2±112.0 | .15 |
| Change | −12.9±78.0 | −26.1±98.0 | .1806 |
| SSCaOx | |||
| Initial collections | 8.0±3.3 | 7.0±2.7 | .012 |
| Subsequent collection | 6.6±3.2 | 3.1±1.5 | <.0001 |
| Change | −1.4±3.5 | −3.9±2.4 | <.0001 |
| UUN level (g/d) | |||
| Initial collections | 9.4±3.3 | 11.0±4.0 | .0055 |
| Subsequent collection | 9.9±3.8 | 11.9±4.1 | <.0001 |
| Change | 0.5±2.6 | 1.0±3.3 | .079 |
| PCR (g/kg per day) | |||
| Initial collections | 0.9±0.2 | 1.0±0.3 | .0016 |
| Subsequent collections | 1.0±0.3 | 1.1±0.2 | <.0001 |
| Change | 0.1±0.2 | 0.1±0.3 | .43 |
| Comorbidities (n=262) | |||
| Heart failure | 6/156 (3.8) | 4/106 (3.8) | .98 |
| Hyponatremia | 9/156 (5.8) | 0/106 (0) | <.05 |
| Cirrhosis | 3/156 (1.9) | 3/106 (2.8) | .63 |
| Medications at presentation (n=262) | |||
| Hydrochlorothiazide | 7/156 (4.5) | 2/106 (1.9) | .26 |
| Chlorthalidone | 48/156 (30.8) | 44/106 (41.5) | .074 |
| Indapamide | 3/156 (1.9) | 1/106 (0.9) | .53 |
| Amiloride | 4/156 (2.6) | 2/106 (1.9) | .72 |
| Furosemide | 5/156 (3.2) | 2/106 (1.9) | .52 |
| Bumetanide | 0/156 (0) | 1/106 (0.9) | .22 |
| Torsemide | 1/156 (0.6) | 0/106 (0) | .41 |
| Potassium citrate | 31/156 (19.9) | 31/106 (29.2) | .080 |
| Sodium bicarbonate | 1/156 (0.6) | 0/106 (0) | .41 |
| Collection day | .59 | ||
| Sunday | 13/165 (7.9) | 6/108 (5.6) | |
| Monday | 48/165 (29.1) | 34/108 (31.5) | |
| Tuesday | 30/165 (18.2) | 22/108 (20.4) | |
| Wednesday | 25/165 (15.2) | 16/108 (14.8) | |
| Thursday | 26/165 (15.8) | 12/108 (11.1) | |
| Friday | 20/165 (12.1) | 12/108 (11.1) | |
| Saturday | 3/165 (1.8) | 6/108 (5.6) | |
| Weekday vs weekend | .71 | ||
| Weekday | 149/165 (90.3) | 96/108 (88.9) | |
| Weekend | 16/165 (9.7) | 12/108 (11.1) | |
BMI = body mass index; PCR = protein catabolic rate; SSCaOx = supersaturation of calcium oxalate; UUN = urine urea nitrogen.
Data are presented as mean ± SD or as number/total number (percentage).
Any P value less than .05.
Creatinine per Kilogram (Cr24/Kg) on the Subsequent Collectiona
| Variable | Urine volume | ||
|---|---|---|---|
| <2.5 L on the subsequent collection | ≥2.5 L on the subsequent collection | ||
| Men | |||
| Initial collection | 18.7±4.0 | 20.5±4.6 | .021 |
| Subsequent collection | 19.8±4.5 | 21.0±4.8 | .13 |
| Change | 1.2±2.8 | 0.5±3.5 | .52 |
| Women | |||
| Initial collection | 16±4.4 | 16.8±4.7 | .66 |
| Subsequent collection | 17.0±4.6 | 18.1±5.3 | .38 |
| Change | 0.9±3.5 | 1.4±3.0 | .77 |
Data are presented as mean ± SD.
Any P value less than .05.